JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
JW THERAP-B: CHANGE OF AUDITOR
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
JW THERAP-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
JW THERAP-B: CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND CHANGE OF COMPOSITION OF BOARD COMMITTEES
JW THERAP-B: VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE NMPA ACCEPTANCE OF SUPPLEMENTAL BIOLOGICAL LICENSE APPLICATION OF CARTEYVA IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY MENTLE CELL LYMPHOMA
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
JW THERAP-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
JW THERAP-B: CHANGE OF CHIEF EXECUTIVE OFFICER, APPOINTMENT, REDESIGNATION AND RESIGNATION OF DIRECTORS, CHANGE OF COMPOSITION OF BOARD COMMITTEES AND CHANGE OF AUTHORIZED REPRESENTATIVE
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
JW THERAP-B: NINTH AMENDED AND RESTATEDMEMORANDUM AND ARTICLES OF ASSOCIATION
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
JW THERAP-B: VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE PRELIMINARY CLINICAL DATA ON RELMA-CEL INJECTION IN ADULTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS IN CHINA AT THE EULAR 2024 CONGRESS
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
JW THERAP-B: Form of proxy for the Annual General Meeting to be held on June 18, 2024
JW THERAP-B: PROPOSED ADOPTION OF NEW ARTICLES OF ASSOCIATION
JW THERAP-B: 2023 Environmental, Social and Governance Report
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
No Data